These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22928748)

  • 21. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.
    Nonaka M; Morimoto S; Murayama T; Kurebayashi N; Li L; Wang YY; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
    Br J Pharmacol; 2015 May; 172(9):2369-82. PubMed ID: 25560565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE; Rush JE; Luis Fuentes V; Glaus T; Summerfield NJ; Wright K; Lehmkuhl L; Wess G; Sayer MP; Loureiro J; MacGregor J; Mohren N
    J Vet Intern Med; 2021 Mar; 35(2):789-800. PubMed ID: 33543810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of intravenous pimobendan administration in dog models of chronic precapillary pulmonary hypertension.
    Morita T; Nakamura K; Osuga T; Kawamoto S; Miki S; Sasaoka K; Takiguchi M
    J Vet Cardiol; 2020 Dec; 32():16-27. PubMed ID: 33080489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH
    Coron Artery Dis; 1994 Feb; 5(2):119-26. PubMed ID: 8180743
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I; Kassel P; Duck HG; Fiehring H; Morgan P; Schmidt PK; Höfs T; Nehmiz G
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.
    Ward JL; Kussin EZ; Tropf MA; Tou SP; DeFrancesco TC; Keene BW
    J Vet Intern Med; 2020 Nov; 34(6):2211-2222. PubMed ID: 33026124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC; Fox PR
    J Vet Intern Med; 2016; 30(2):553-9. PubMed ID: 26936799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compounded pimobendan for canine chronic degenerative mitral valve disease and pulmonary hypertension.
    Helms SR; Fox S; Mixon W; Vail J
    Int J Pharm Compd; 2012; 16(1):34-41. PubMed ID: 23050309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pimobendan has a potent venodilating action in patients with congestive heart failure.
    Matsumoto A; Momomura S; Yokoyama I; Aoyagi T; Sugiura S; Omata M
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):595-7. PubMed ID: 10410829
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-64. PubMed ID: 2478785
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and treatment of congestive heart failure secondary to dilated cardiomyopathy in a hedgehog.
    Delk KW; Eshar D; Garcia E; Harkin K
    J Small Anim Pract; 2014 Mar; 55(3):174-7. PubMed ID: 24372164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC; Diederen W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure.
    Kubo SH
    Cardiology; 1997; 88 Suppl 2():21-7. PubMed ID: 9142432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW; Jöns O; Bussadori CM
    J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
    Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
    Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
    J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.